Effect on survival of ADT alone compared to ADT combined with concurrent RT to the prostate in patients with primary bone metastatic PCa in a prospective randomised clinical trial: data from the HORRAD trial
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
The LANCET Oncology 2018 Nov 20, Volume 20, Issue 1, Pages 100-109
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial
Lancet Oncol., Volume 19, Issue 10, September 2018, Pages 1404-1416
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imagingtargeted and Systematic Biopsies
High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
UK single centre experience of rare and atypical variant of castrate-resistant prostate cancer: Poorly differentiated neuroendocrine small-cell carcinoma
Journal of Clinical Urology, Volume 8, Pages 19-29